Overview

A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain

Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to determine the overall analgesic efficacy and safety of a fixed-dose ibuprofen 250 mg / acetaminophen 500 mg formulation compared to placebo in subjects who are experiencing post operative pain following surgical extraction of 3 or more third molar teeth. A review of any reported adverse events will also be completed.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Acetaminophen
Ibuprofen